"As a child, I found going to the lab fascinating, I saw over time how these new treatments were developed and then made accessible to patients who needed them. This inspired me to pursue a career in the healthcare sector."

60 seconds with Ciaran Gallagher, Analyst

Q: Tell us about you

A: I completed my BA in Business and Management as well as a certificate of higher applied science in the field of Biological Sciences at the University of Reading. Whilst there I completed modules in endocrinology, immunology and oncology and molecular genetics, going on to complete a dissertation in endocrine neoplasia and cancer. Once I completed university, I worked for Precious Cells, a stem cell research company. Following this I joined PricewaterhouseCoopers as an Assurance Associate, gaining experience in economic analysis and data driven research. I am really excited to combine my passion for medical science and my acumen for business and economics here at Lightning Health.

In my spare time I love to cook, always on the hunt to create new and interesting recipes and try new flavours. I also very much enjoy hiking and long-distance running, I plan to run six half marathons for charity in six months this year!

 

Q: What is your role at Lightning Health?

A: In my role as an Analyst, I assist clients in gaining on-demand insights from payers and physician stakeholders through our global network and using the Lightning Insights technology. I conduct research and collaborate with the experts and industry professionals, actioning analysis of the data to give our clients valuable insights. I am also responsible for performing strategic market access and pricing analysis, and provide data driven recommendations. My experience has well equipped me to perform these tasks and to be an asset here at Lightning Health.

 

Q: Tell us more about your passion for scientific research

A: My passion for scientific research and the development of new, innovative treatments started early on. My mother, Prof. Fionula Brennan conducted cutting edge research at the Kennedy Institute of Rheumatology. Her work helped to contribute to a new era of therapeutics, and an anti-TNF was later approved for use in other inflammatory conditions including Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriasis and psoriatic arthritis. As a child, I found going to the lab fascinating, I saw over time how these new treatments were developed and then made accessible to patients who needed them. This inspired me to pursue a career in healthcare.

What motivates me is working in a sector where I support in bringing life changing treatments to patients, while expanding my scientific knowledge.

 

 

Article published 28 March 2022.